Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Leo Pharma AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 14,222 Less Arrow 13,839 More Arrow 14,186
Financial expenses 260 More Arrow 344 Less Arrow 209
Earnings before taxes 456 Less Arrow 378 More Arrow 557
EBITDA 551 Less Arrow 534 More Arrow 588
Total assets 7,986 More Arrow 9,118 More Arrow 11,884
Current assets 7,605 More Arrow 8,555 More Arrow 11,171
Current liabilities 3,299 More Arrow 5,371 More Arrow 7,356
Equity capital 3,203 Less Arrow 2,967 Less Arrow 2,679
- share capital 87 More Arrow 90 Equal arrow 90
Employees (average) 21 More Arrow 23 Less Arrow 18

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 40.1% Less Arrow 32.5% Less Arrow 22.5%
Turnover per employee 677 Less Arrow 602 More Arrow 788
Profit as a percentage of turnover 3.2% Less Arrow 2.7% More Arrow 3.9%
Return on assets (ROA) 9.0% Less Arrow 7.9% Less Arrow 6.4%
Current ratio 230.5% Less Arrow 159.3% Less Arrow 151.9%
Return on equity (ROE) 14.2% Less Arrow 12.7% More Arrow 20.8%
Change turnover 853 Less Arrow -388 Less Arrow -1,393
Change turnover % 6% Less Arrow -3% Less Arrow -9%
Chg. No. of employees -2 More Arrow 5 Less Arrow -13
Chg. No. of employees % -9% More Arrow 28% Less Arrow -42%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.